303 related articles for article (PubMed ID: 17187248)
1. Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.
Miyamoto N; de Kozak Y; Jeanny JC; Glotin A; Mascarelli F; Massin P; BenEzra D; Behar-Cohen F
Diabetologia; 2007 Feb; 50(2):461-70. PubMed ID: 17187248
[TBL] [Abstract][Full Text] [Related]
2. PlGF-1 and VEGFR-1 pathway regulation of the external epithelial hemato-ocular barrier. A model for retinal edema.
Miyamoto N; de Kozak Y; Normand N; Courtois Y; Jeanny JC; Benezra D; Behar-Cohen F
Ophthalmic Res; 2008; 40(3-4):203-7. PubMed ID: 18421240
[TBL] [Abstract][Full Text] [Related]
3. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
Deissler HL; Deissler H; Lang GK; Lang GE
Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
[TBL] [Abstract][Full Text] [Related]
4. Basal and apical regulation of VEGF-A and placenta growth factor in the RPE/choroid and primary RPE.
Klettner A; Kaya L; Flach J; Lassen J; Treumer F; Roider J
Mol Vis; 2015; 21():736-48. PubMed ID: 26167115
[TBL] [Abstract][Full Text] [Related]
5. VEGF modulation of retinal pigment epithelium resistance.
Ablonczy Z; Crosson CE
Exp Eye Res; 2007 Dec; 85(6):762-71. PubMed ID: 17915218
[TBL] [Abstract][Full Text] [Related]
6. Human retinal epithelium produces and responds to placenta growth factor.
Hollborn M; Tenckhoff S; Seifert M; Köhler S; Wiedemann P; Bringmann A; Kohen L
Graefes Arch Clin Exp Ophthalmol; 2006 Jun; 244(6):732-41. PubMed ID: 16341703
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
8. Decorin Prevents Retinal Pigment Epithelial Barrier Breakdown Under Diabetic Conditions by Suppressing p38 MAPK Activation.
Wang S; Du S; Wu Q; Hu J; Li T
Invest Ophthalmol Vis Sci; 2015 May; 56(5):2971-9. PubMed ID: 25829413
[TBL] [Abstract][Full Text] [Related]
9. Osmotic induction of placental growth factor in retinal pigment epithelial cells in vitro: contribution of NFAT5 activity.
Hollborn M; Reichmuth K; Prager P; Wiedemann P; Bringmann A; Kohen L
Mol Biol Rep; 2016 Aug; 43(8):803-14. PubMed ID: 27230578
[TBL] [Abstract][Full Text] [Related]
10. Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in medium-term culture.
Geisen P; McColm JR; King BM; Hartnett ME
Curr Eye Res; 2006 Sep; 31(9):739-48. PubMed ID: 16966147
[TBL] [Abstract][Full Text] [Related]
11. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
Deissler HL; Lang GK; Lang GE
Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
[TBL] [Abstract][Full Text] [Related]
12. δ Opioid Receptor Agonism Preserves the Retinal Pigmented Epithelial Cell Tight Junctions and Ameliorates the Retinopathy in Experimental Diabetes.
Lopes de Faria JM; Duarte DA; Simó R; García-Ramirez M; Dátilo MN; Pasqualetto FC; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2019 Sep; 60(12):3842-3853. PubMed ID: 31529081
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of apical and basolateral VEGF-A and VEGF-C secretion by oxidative stress in polarized retinal pigment epithelial cells.
Kannan R; Zhang N; Sreekumar PG; Spee CK; Rodriguez A; Barron E; Hinton DR
Mol Vis; 2006 Dec; 12():1649-59. PubMed ID: 17200665
[TBL] [Abstract][Full Text] [Related]
14. Placental growth factor stabilizes VEGF receptor-2 protein in retinal pigment epithelial cells by downregulating glycogen synthase kinase 3 activity.
Murata M; Noda K; Kase S; Hase K; Wu D; Ando R; Ishida S
J Biol Chem; 2022 Sep; 298(9):102378. PubMed ID: 35970387
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Antiplacental Growth Factor Antibody Against Light-Induced Retinal Damage in Mice.
Izawa H; Inoue Y; Ohno Y; Ojino K; Tsuruma K; Shimazawa M; Hara H
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6914-24. PubMed ID: 26513607
[TBL] [Abstract][Full Text] [Related]
16. Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.
Shyong MP; Lee FL; Kuo PC; Wu AC; Cheng HC; Chen SL; Tung TH; Tsao YP
Mol Vis; 2007 Jan; 13():133-41. PubMed ID: 17293777
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats.
Huang J; Li X; Li M; Li S; Xiao W; Chen X; Cai M; Wu Q; Luo D; Tang S; Luo Y
Diabetes Obes Metab; 2012 Jul; 14(7):644-53. PubMed ID: 22340191
[TBL] [Abstract][Full Text] [Related]
18. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
19. Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition.
Huang H; He J; Johnson D; Wei Y; Liu Y; Wang S; Lutty GA; Duh EJ; Semba RD
Diabetes; 2015 Jan; 64(1):200-12. PubMed ID: 25187372
[TBL] [Abstract][Full Text] [Related]
20. Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown.
Kuo C; Green CR; Rupenthal ID; Mugisho OO
Acta Diabetol; 2020 Jan; 57(1):13-22. PubMed ID: 31030263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
